skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Multiple myeloma: patient outcomes in real‐world practice
Multiple myeloma: patient outcomes in real‐world practice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multiple myeloma: patient outcomes in real‐world practice

Yong, Kwee ; Delforge, Michel ; Driessen, Christoph ; Fink, Leah ; Flinois, Alain ; Gonzalez‐McQuire, Sebastian ; Safaei, Reza ; Karlin, Lionel ; Mateos, Maria‐Victoria ; Raab, Marc S. ; Schoen, Paul ; Cavo, Michele

British journal of haematology, 2016-10, Vol.175 (2), p.252-264 [Periódico revisado por pares]

England: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
2
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Walter, Harriet S. ; Rule, Simon A. ; Dyer, Martin J.S. ; Karlin, Lionel ; Jones, Ceri ; Cazin, Bruno ; Quittet, Philippe ; Shah, Nimish ; Hutchinson, Claire V. ; Honda, Hideyuki ; Duffy, Kevin ; Birkett, Joseph ; Jamieson, Virginia ; Courtenay-Luck, Nigel ; Yoshizawa, Toshio ; Sharpe, John ; Ohno, Tomoya ; Abe, Shinichiro ; Nishimura, Akihisa ; Cartron, Guillaume ; Morschhauser, Franck ; Fegan, Christopher ; Salles, Gilles

Blood, 2016-01, Vol.127 (4), p.411-419 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Multiple myeloma: practice patterns across Europe
Multiple myeloma: practice patterns across Europe
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multiple myeloma: practice patterns across Europe

Raab, Marc S. ; Cavo, Michele ; Delforge, Michel ; Driessen, Christoph ; Fink, Leah ; Flinois, Alain ; Gonzalez‐McQuire, Sebastian ; Safaei, Reza ; Karlin, Lionel ; Mateos, Maria‐Victoria ; Schoen, Paul ; Yong, Kwee

British journal of haematology, 2016-10, Vol.175 (1), p.66-76 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

Amorim, Sandy, MD ; Stathis, Anastasios, MD ; Gleeson, Mary, FRCPath ; Iyengar, Sunil, MD ; Magarotto, Valeria, MD ; Leleu, Xavier, Prof ; Morschhauser, Franck, Prof ; Karlin, Lionel, MD ; Broussais, Florence, MD ; Rezai, Keyvan, ScD ; Herait, Patrice, MD ; Kahatt, Carmen, MD ; Lokiec, François, PhD ; Salles, Gilles, Prof ; Facon, Thierry, Prof ; Palumbo, Antonio, Prof ; Cunningham, David, Prof ; Zucca, Emanuele, MD ; Thieblemont, Catherine, Prof

The Lancet. Haematology, 2016-04, Vol.3 (4), p.e196-e204 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis
Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis

Facon, Thierry ; Moreau, Philippe ; Baker, Ross ; Min, Chang-Ki ; Leleu, Xavier ; Mohty, Mohamad ; Karlin, Lionel ; Armstrong, Nicole M ; Tekle, Christina ; Schwab, Sandrine ; Risse, Marie-Laure ; Martin, Thomas

Haematologica (Roma), 2024-02, Vol.109 (2), p.604-616 [Periódico revisado por pares]

Italy: Fondazione Ferrata Storti

Texto completo disponível

Citações Citado por
6
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study

Wang, Michael ; Ramchandren, Radhakrishnan ; Chen, Robert ; Karlin, Lionel ; Chong, Geoffrey ; Jurczak, Wojciech ; Wu, Ka Lung ; Bishton, Mark ; Collins, Graham P ; Eliadis, Paul ; Peyrade, Frédéric ; Lee, Yihua ; Eckert, Karl ; Neuenburg, Jutta K ; Tam, Constantine S

Journal of hematology and oncology, 2021-10, Vol.14 (1), p.1-179, Article 179 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

Kreitman, Robert J ; Dearden, Claire ; Zinzani, Pier Luigi ; Delgado, Julio ; Robak, Tadeusz ; le Coutre, Philipp D ; Gjertsen, Bjørn T ; Troussard, Xavier ; Roboz, Gail J ; Karlin, Lionel ; Gladstone, Douglas E ; Kuptsova-Clarkson, Nataliya ; Liu, Shiyao ; Patel, Priti ; Rotolo, Federico ; Mitry, Emmanuel ; Pastan, Ira ; Giles, Francis

Journal of hematology and oncology, 2021-02, Vol.14 (1), p.35-11, Article 35 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Real life management of patients hospitalized with multiple myeloma in France
Real life management of patients hospitalized with multiple myeloma in France
Material Type:
Artigo 		Adicionar ao Meu Espaço

Real life management of patients hospitalized with multiple myeloma in France

Dumontet, Charles ; Couray-Targe, Sandrine ; Teisseire, Marion ; Karlin, Lionel ; Maucort-Boulch, Delphine Reddy, Sakamuri V.

PloS one, 2018-05, Vol.13 (5), p.e0196596-e0196596 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
9
All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study
All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study

Touzeau, Cyrille ; Perrot, Aurore ; Roussel, Murielle ; Karlin, Lionel ; Benboubker, Lotfi ; Jacquet, Caroline ; Mohty, Mohamad ; Facon, Thierry ; Manier, Salomon ; Chretien, Marie-Lorraine ; Tiab, Mourad ; Hulin, Cyrille ; Leleu, Xavier ; Loiseau, Hervé Avet ; Dejoie, Thomas ; Planche, Lucie ; Attal, Michel ; Moreau, Philippe

Haematologica (Roma), 2022-07, Vol.107 (7), p.1693-1697 [Periódico revisado por pares]

Fondazione Ferrata Storti

Texto completo disponível

Citações Citado por
10
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study
Material Type:
Artigo 		Adicionar ao Meu Espaço

ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study

Ocio, Enrique M ; Efebera, Yvonne A ; Hájek, Roman ; Straub, Jan ; Maisnar, Vladimir ; Eveillard, Jean-Richard ; Karlin, Lionel ; Mateos, María-Victoria ; Oriol, Albert ; Ribrag, Vincent ; Richardson, Paul G ; Norin, Stefan ; Obermüller, Jakob ; Bakker, Nicolaas A ; Pour, Luděk

Haematologica (Roma), 2024-03, Vol.109 (3), p.867-876 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (344)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (350)
  2. Anais de Congresso  (2)
  3. Web Resources  (1)
  4. Reports  (1)
  5. Dissertações  (1)
  6. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2009  (5)
  2. 2009Até2012  (14)
  3. 2013Até2016  (91)
  4. 2017Até2021  (139)
  5. Após 2021  (106)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (348)
  2. Japonês  (11)
  3. Francês  (7)
  4. Norueguês  (2)
  5. Alemão  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.